ANIP icon

ANI Pharmaceuticals

146 hedge funds and large institutions have $337M invested in ANI Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 65 increasing their positions, 28 reducing their positions, and 23 closing their positions.

Holders
146
Holders Change
-5
Holders Change %
-3.31%
% of All Funds
3.65%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
18
Increased
65
Reduced
28
Closed
23
Calls
$1.72M
Puts
$14M
Net Calls
-$12.3M
Net Calls Change
-$3.52M
Name Market Value Shares Shares
Change
Shares
Change %
VFA
151
Virtus Fund Advisers
Connecticut
-6,188 Closed
Squarepoint
152
Squarepoint
New York
-6,097 Closed
AQR Capital Management
153
AQR Capital Management
Connecticut
-5,264 Closed
DTL
154
Dynamic Technology Lab
Singapore
-4,485 Closed
SCM
155
Stevens Capital Management
Pennsylvania
-4,417 Closed
Simplex Trading
156
Simplex Trading
Illinois
-4,387 Closed
Creative Planning
157
Creative Planning
Kansas
-2,218 Closed
Victory Capital Management
158
Victory Capital Management
Texas
-1,905 Closed
WAM
159
Wolverine Asset Management
Illinois
-1,135 Closed
QT
160
Quantbot Technologies
New York
-142 Closed
AIM
161
Acrospire Investment Management
Illinois
-48 Closed
FPFS
162
First Personal Financial Services
North Carolina
-41 Closed
WEC
163
Winslow Evans & Crocker
Massachusetts
-8 Closed
VCM
164
Versant Capital Management
Arizona
$0 10
AC
165
Alexandria Capital
Virginia
$0 7
DAM
166
DLD Asset Management
New York
WVP
167
Worth Venture Partners
New Jersey
Carson Wealth (CWM LLC)
168
Carson Wealth (CWM LLC)
Nebraska
$0 5
Group One Trading
169
Group One Trading
Illinois
JCM
170
Jacobi Capital Management
Pennsylvania
$0 5
WAM
171
Wealthspire Advisors (Maryland)
Maryland
$0 2 +2 New
PFBT
172
Parkside Financial Bank & Trust
Missouri
$0 6 +6 New